NHS issues 'serious shortage' warning for 4 drugs used for angina

Jake Holden
·2-min read
Four drugs used to treat the heart condition angina were issued with serious shortage warnings by the NHS this month
-Credit: (Image: Getty)


Four drugs used to treat the heart condition angina are at risk of 'serious shortage' the NHS has said this month. Nyzamac capsules, Monomil tablets, Monomax tablets and Chemydur tablets all have been added to the Serious Shortage Protocol (SSP) on the NHS website.

This means that patients could see their regular prescriptions be substituted with alternative drugs while supplies remain short, the NHS said. Four other drugs treating various medical conditions are also on a serious shortage.

Each of the shortages of these four drugs has a different end date but they were all issued on September 6. Here is the list of the specific drugs and the dates the serious shortages are expected to last until:

READ MORE: Kate Middleton and Prince William's heartfelt gesture to Peckham food bank raided by thieves

Monomil has the most serious shortage lasting four months into January next year. Nyzmac only will be on an SSP for two months, Monomax for just over one month and Chemydur for less than a month.

There are several specific criteria for patients on these drugs to be included in having their usual prescription substituted or to be excluded from substitution based on detailed medical evaluation. Click on the links above next to each drug to see whether these apply to you.

The four other drugs also on SSP are older shortages which are still in force. These are as follows:

Get the biggest stories from around London straight to your inbox. Sign up to MyLondon's The 12 HERE for the 12 biggest stories each day.

Latest stories